Inventor · disambiguated record
Cheng-I Wang
Also filed as: WANG CHENG · WANG CHENG-I
36 granted patents·18 pending applications·220 citations·filing 2007–2025
97Inventor score
Files withAGENCY SCIENCE TECH & RES34SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD5CAMBRIOS TECHNOLOGIES CORP2CHUGAI PHARMACEUTICAL CO LTD2UNIV CHINA AGRICULTURAL2
Top patents by PatentIndex Score
54 records- 0195US9758583B2Anti-CTLA-4 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Sep 12, 2017·48 cites·17 claims
- 0294US9789183B1Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Oct 17, 2017·13 cites·20 claims
- 0392US10472423B2IL2Rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Nov 12, 2019·7 cites·5 claims
- 0492US9122669B2Flat schema integrated document oriented templatesDEMANT HILMAR·Filed 2008·Granted Sep 1, 2015·72 cites·18 claims
- 0590US10696747B2IL2R common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Jun 30, 2020·4 cites·5 claims
- 0690US10517949B2Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Dec 31, 2019·8 cites·12 claims
- 0790US9771425B2Anti-PD-1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Sep 26, 2017·10 cites·20 claims
- 0889US9738704B2Binding molecules against Chikungunya virus and uses thereofAGENCY SCIENCE TECH & RES·Filed 2016·Granted Aug 22, 2017·6 cites·13 claims
- 0988US10246512B2IL-2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Apr 2, 2019·6 cites·6 claims
- 1086US10919962B2Method of reducing tumor growth with IL-1beta neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2018·Granted Feb 16, 2021·4 cites·14 claims
- 1184US12472252B2Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2022·Granted Nov 18, 2025·0 cites·19 claims
- 1284US10259874B2Anti-TIM-3 antibodiesAGENCY SCIENCE TECH & RES·Filed 2015·Granted Apr 16, 2019·6 cites·13 claims
- 1384US10167338B2Method of treating cancer using IL2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Jan 1, 2019·4 cites·2 claims
- 1484US10167335B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2013·Granted Jan 1, 2019·6 cites·17 claims
- 1583US7976726B2Prevention of quantum dot quenching on metal surfacesSILURIA TECHNOLOGIES INC·Filed 2007·Granted Jul 12, 2011·12 cites·13 claims
- 1682US11534489B2Anti-PD-L1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Granted Dec 27, 2022·1 cites·9 claims
- 1782US10472421B2Method for expansion of a population of cells with IL2R beta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2016·Granted Nov 12, 2019·3 cites·7 claims
- 1880US9441032B2Binding molecules against Chikungunya virus and uses thereofWARTER LUCILE·Filed 2011·Granted Sep 13, 2016·6 cites·13 claims
- 1978US12297265B2Antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted May 13, 2025·1 cites·43 claims
- 2077US12258419B2Anti-FXI/FXIa antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 25, 2025·1 cites·27 claims
- 2174US11912761B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2021·Granted Feb 27, 2024·0 cites·18 claims
- 2274US11702471B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2021·Granted Jul 18, 2023·0 cites·20 claims
- 2373US11780913B2IL-1β neutralizing human monoclonal antibodiesAGENCY SCIENCE TECH & RES·Filed 2020·Granted Oct 10, 2023·0 cites·9 claims
- 2471US2024052046A1Il2rbeta/common gamma chain antibodiesAGENCY SCIENCE TECH & RES·Filed 2023·Application pending·0 cites
- 2571US2024190948A1Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2670US10280224B2Anti-PD-1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2015·Granted May 7, 2019·1 cites·16 claims
- 2770US2025340630A1Antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 2867US11072659B2Anti-PD-1 antibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Granted Jul 27, 2021·0 cites·20 claims
- 2967US10435466B2Anti-TIM-3 antibodiesAGENCY SCIENCE TECH & RES·Filed 2015·Granted Oct 8, 2019·1 cites·9 claims
- 3062US12404341B2Glypican-3 (GPC-3) antibodiesAGENCY SCIENCE TECH & RES·Filed 2020·Granted Sep 2, 2025·0 cites·24 claims
- 3162US10446123B2Intuitive music visualization using efficient structural segmentationADOBE INC·Filed 2018·Granted Oct 15, 2019·0 cites·20 claims
- 3260US11891432B2Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 6, 2024·0 cites·2 claims
- 3360US2025327052A1Recombinant/Fusion Polypeptides Comprising Mutated Angiotensin Converting Enzyme 2 (ACE2)AGENCY SCIENCE TECH & RES·Filed 2022·Application pending·0 cites
- 3458US11142574B2Anti-TIM-3 antibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Granted Oct 12, 2021·0 cites·12 claims
- 3557US11267887B2Anti-CTLA-4 antibodiesAGENCY SCIENCE TECH & RES·Filed 2017·Granted Mar 8, 2022·0 cites·14 claims
- 3655US2025042990A1Anti-il-1-beta antibodiesLILLY CO ELI·Filed 2022·Application pending·0 cites
- 3754US2025223352A2Anti-nectin-4 antibody, conjugate including the same, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3853US2022222294A1Densification in Music Search and RecommendationSMULE INC·Filed 2021·Application pending·0 cites
- 3953US2023338565A1Antibody drug conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 4051US10074350B2Intuitive music visualization using efficient structural segmentationADOBE SYSTEMS INC·Filed 2015·Granted Sep 11, 2018·0 cites·20 claims
- 4151US2020055935A1Anti-TIM-3 AntibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Application pending·0 cites
- 4247US2022340684A1Modified fc regionAGENCY SCIENCE TECH & RES·Filed 2019·Application pending·0 cites
- 4345US2023080224A1Antigen-binding molecules against alppl2 and/or alpp and uses thereofAGENCY SCIENCE TECH & RES·Filed 2021·Application pending·0 cites
- 4444US2014349321A1Binding molecules against dengue virus and uses thereofAGENCY SCIENCE TECH & RES·Filed 2012·Application pending·0 cites
- 4543US2020140491A1Tropism-Modified Recombinant Viral Vectors and Uses Thereof for the Targeted Introduction of Genetic Material into Human CellsREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 4642US11945877B2Anti-HER2 antibodiesAGENCY SCIENCE TECH & RES·Filed 2019·Granted Apr 2, 2024·0 cites·17 claims
- 4742US2009305437A1Fabrication of inorganic materials using templates with labile linkageCAMBRIOS TECHNOLOGIES CORP·Filed 2007·Application pending·0 cites
- 4841US10563219B2Corn genes ZmSPL1 and ZmSPL2 and uses thereofUNIV CHINA AGRICULTURAL·Filed 2013·Granted Feb 18, 2020·0 cites·11 claims
- 4940US2009052029A1Functional films formed by highly oriented deposition of nanowiresCAMBRIOS TECHNOLOGIES CORP·Filed 2007·Application pending·0 cites
- 5039US10711066B2Anti-canine platelet derived growth factor receptor alpha antibodyELANCO US INC·Filed 2017·Granted Jul 14, 2020·0 cites·6 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Cheng-I Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →